FORUM MARKETS Inc current report, Q4 FY2023

Business Context and Reporting Period

This Form 8-K is filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on October 11, 2023. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding compliance with listing rules.

Key Financial Metrics

This filing is a current report regarding a listing compliance issue and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for these metrics.

Material Changes and Events

  • Nasdaq Non-Compliance Notice: The Company received a Notification Letter stating it failed to comply with Nasdaq Listing Rule 5635(d).
  • Triggering Transaction: The non-compliance stems from an offering completed in August 2023 involving:
    • 666,925 shares of Common Stock at $0.65 per share.
    • Pre-funded warrants for 3,948,460 shares at $0.6499 per warrant.
    • Common warrants for 4,615,385 shares.
  • Reason for Violation: The offering represented greater than 20% of pre-transaction shares outstanding and was priced below the Minimum Price. Nasdaq determined shareholder approval was required because the offering was not a "public offering" (one investor purchased 98% of the offering).

Outlook, Risks, and Management Commentary

  • Current Listing Status: The Notification Letter does not immediately impact the Company's listing on the Nasdaq Capital Market.
  • Compliance Timeline: The Company has 45 days to submit a plan to regain compliance. If accepted, Nasdaq may grant an additional 180-day extension to evidence compliance.
  • Risks: There is no assurance that Nasdaq will accept the Company's plan or that the Company will successfully regain compliance with listing requirements.

Investor Verification Checklist

  • Verify the Company's plan to regain compliance with Nasdaq Listing Rule 5635(d) within the 45-day window.
  • Monitor for any subsequent filings regarding the acceptance or rejection of the compliance plan by Nasdaq.
  • Review the August 15, 2023 Form 8-K for full details on the capital raise transaction that triggered this notice.
  • Confirm the Company's current cash position and runway, as this filing does not provide updated financial data.